Gema Fernández‐Juárez

Author

Hospital Universitario Fundación Alcorcón ORCID

Also Known As

Fernández-Juárez, G., G Fernandez-Juarez, G Fernández-Juarez, G Fernández-Juárez, G. FernAndez-JuArez, G. Fernandez-Juarez, G. Fernandez-Juárez, G. Fernández-Juárez, G.M. Fernández-Juarez, Gema Fernandez Juarez

191

Publications

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Fundación Alcorcón Hospital Universitario 12 De Octubre Hospital Universitario Ramón y Cajal Universidad Complutense de Madrid Hospital Universitario La Paz

About

Gema Fernández‐Juárez is an author at Hospital Universitario Fundación Alcorcón specializing in medicine, nephrology, and chronic kidney disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	1K
2	Immunology	6	6	170
3	Allergy	1	1	21
4	Diabetes	1	1	22
5	Endocrinology	1	1	55

Gema Fernández‐Juárez

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Spontaneous Remission of Nephrotic Syndrome in Idiopathic Membranous Nephropathy Natalia Polanco, Elena Gutiérrez, A Covarsí, Journal of the American Society of Nephrology Glomerular DiseaseGlomerulonephritisUrologyRenal DiseaseRenal Function	2010	371
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy Gema Fernández‐Juárez, Jorge Rojas-Rivera, Anne-Els van de Logt, Kidney International	2020	220
Effectiveness of mycophenolate mofetil in C3 glomerulonephritis Cristina Rabasco, Teresa Cavero, Elena Román, Kidney International GlomerulonephritisMycophenolate MofetilRenal FunctionMedicineChronic Kidney Disease	2015	165
Duration of Treatment with Corticosteroids and Recovery of Kidney Function in Acute Interstitial Nephritis Gema Fernández‐Juárez, Javier Villacorta Pérez, Fernando Caravaca‐Fontán, Clinical Journal of the American Society of Nephrology	2018	122
25 (OH) Vitamin D Levels and Renal Disease Progression in Patients with Type 2 Diabetic Nephropathy and Blockade of the Renin-Angiotensin System Gema Fernández‐Juárez, José Luño, V. Barrio, Clinical Journal of the American Society of Nephrology	2013	91
Clinical and pathological phenotype of genetic causes of focal segmental glomerulosclerosis in adults Nicola Lepori, Ladan Zand, Sanjeev Sethi, Clinical Kidney Journal Glomerular DiseaseGenetic CausesRenal PathologyPathologyGlomerulonephritis	2017	78
Mycophenolate Mofetil in C3 Glomerulopathy and Pathogenic Drivers of the Disease Fernando Caravaca‐Fontán, Montserrat M. Díaz Encarnación, Laura Lucientes, Clinical Journal of the American Society of Nephrology	2020	73
Serum interleukin-6 levels predict kidney disease progression in diabetic nephropathy Beatriz Sánchez‐Álamo, Amir Shabaka, Victoria Cachofeiro, Clinical Nephrology	2021	63
Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study) Marián Goicoechea, Soledad García de Vinuesa, Borja Quiroga, Cardiovascular Drugs and Therapy Primary PreventionRenal FunctionRenal CareCardiovascular DiseaseMedicine	2018	58
A European multicentre and open-label controlled randomized trial to evaluate the efficacy of<i>S</i>equential treatment with TAcrolimus–Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy: the STARMEN study Jorge Rojas-Rivera, Gema Fernández‐Juárez, Alberto Ortíz, Clinical Kidney Journal	2015	57

Page 1